Genome-wide analysis in UK Biobank identifies four loci associated with mood instability and genetic correlation with major depressive disorder, anxiety disorder and schizophrenia

Translational Psychiatry

Volumn 7, Issue 11, 2017, Pages

  Ward, Joey ^a   Strawbridge, Rona J ^a,b   Bailey, Mark E S ^a   Graham, Nicholas ^a   Ferguson, Amy ^a   Lyall, Donald M ^a   Cullen, Breda ^a   Pidgeon, Laura M ^a   Cavanagh, Jonathan ^a   Mackay, Daniel F ^a   Pell, Jill P ^a   O'Donovan, Michael ^c   Escott Price, Valentina ^c   Smith, Daniel J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BIOBANK; CHROMOSOME 14; CHROMOSOME 18; CHROMOSOME 8; CHROMOSOME 9; CONTROLLED STUDY; DCC GENE; EIF2B2 GENE; FEMALE; GENE; GENE LOCUS; GENETIC CORRELATION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL INSTABILITY; MIDDLE AGED; PGF GENE; PHENOTYPE; POSTTRAUMATIC STRESS DISORDER; PTPRD GENE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; UNITED KINGDOM; AFFECT; AGED; BIPOLAR DISORDER; GENETICS; MULTIFACTORIAL INHERITANCE; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES;

ADULT; AFFECT; AGED; ANXIETY DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BIOLOGICAL SPECIMEN BANKS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MIDDLE AGED; MULTIFACTORIAL INHERITANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; STRESS DISORDERS, POST-TRAUMATIC; UNITED KINGDOM;

EID: 85036586536     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/s41398-017-0012-7     Document Type: Article

References (50)

1. Balbuena, L., Bowen, R., Baetz, M. & Marwaha, S. Mood instability and irritability as core symptoms of major depression: an exploration using rasch analysis. Front. Psychiatry 7, 174 (2016).
2. Marwaha, S., Parsons, N., Flanagan, S. & Broome, M. The prevalence and clinical associations of mood instability in adults living in England: results from the adult psychiatric morbidity survey 2007. Psychiatr. Res. 205, 262-268 (2013).
3. Cuthbert, B. & Insel, T. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 11, 126 (2013).
4. Broome, M. R., Saunders, K. E. A., Harrison, P. J. & Marwaha, S. Mood instability: significance, definition and measurement. Br. J. Psychiatry 207, 283-285 (2015).
5. Marwaha, S. et al. Affective instability, childhood trauma and major affective disorders. J. Affect. Disord. 190, 764-771 (2016).
6. Howes, O. D. et al. A comprehensive review and model of putative prodromal features of bipolar affective disorder. Psychol. Med. 41, 1567-1577 (2011).
7. Strejilevich, S. A. et al. Mood instability and functional recovery in bipolar disorders. Acta Psychiatr. Scand. 128, 194-202 (2013).
8. Coccaro, E. F.,Ong, A.D., Seroczynski, A.D. & Bergeman, C. S. Affective intensity and lability: heritability in adult male twins. J. Affect. Disord. 136, 1011-1016 (2012).
9. Marwaha, S. et al. How is affective instability defined and measured? A systematic review. Psychol. Med. 44, 1793-1808 (2014).
10. Sudlow, C. et al. UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 12, e1001779 (2015).
11. Eysenck, S. B. G., Eysenck, H. J. & Barrett, P. A revised version of the psychoticism scale. Pers. Individ. Dif. 6, 21-29 (1985).
12. UK Biobank. Genotype imputation and genetic association studies of UK Biobank, Interim Data Release, 11 September 2015; http://www.ukbiobank.ac. uk/wp-content/uploads/2014/04/imputation-documentation-May2015.pdf.
13. Delaneau, O., Zagury, J.-F. & Marchini, J. Improved whole-chromosome phasing for disease and population genetic studies. Nat. Method 10, 5-6 (2013).
14. Howie, B., Marchini, J. & Stephens, M. Genotype imputation with thousands of genomes. G3 1, 457 (2011).
15. Huang, J. et al. Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. Nat. Commun. 6, 8111 (2015).
16. UK Biobank. Genotyping of 500,000 UK Biobank participants. Description of sample processing workflow and preparation of DNA for genotyping, 11 September 2015; https://biobank.ctsu.ox.ac.uk/crystal/docs/genotyping- sample-workflow.pdf.
17. Purcell S. et al. PLINK: A Tool Set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
18. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291-295 (2015).
19. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236-1241 (2015).
20. Bipolar Disorder Working Group of the Psychiatric Genomics Consortium. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet. 43, 977-983 (2011).
21. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
22. Major Depressive Disorder Working Group of the Psychiatric Genomics Consortium. A mega-analysis of genome-wide association studies for major depressive disorder. Mol. Psychiatry 18, 497-511 (2013).
23. Neale, B. M. et al. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 49, 884-897 (2010).
24. Otowa, T. et al. Meta-analysis of genome-wide association studies of anxiety disorders. Mol. Psychiatry 21, 1391-1399 (2016).
25. Duncan, L. E. et al. Largest GWAS of PTSD (N = 20[thinsp]070) yields genetic overlap with schizophrenia and sex differences in heritability. Mol. Psychiatry (2017).
26. Smith, D. J. et al. Prevalence and characteristics of probable major depression and bipolar disorder within UK Biobank: cross-sectional study of 172,751 participants. PLoS ONE 8, e75362 (2013).
27. Mennin, D. S. & Fresco, D. M. What, me worry and ruminate about DSM-5 and RDoC? The importance of targeting negative self-referential processing. Clin. Psychol. 20, 258-267 (2013).
28. Manitt, C. et al. The Netrin receptor DCC is required in the pubertal organization of mesocortical dopamine circuitry. J. Neurosci. 31, 8381-8394 (2011).
29. Jamuar, S. S. et al. Biallelic mutations in human DCC cause developmental split-brain syndrome. Nat. Genet. 49, 606-612 (2017).
30. Marsh, A. P. L. et al. Mutations in DCC cause isolated agenesis of the corpus callosum with incomplete penetrance. Nat. Genet. 49, 511-514 (2017).
31. Manitt, C. et al. dcc orchestrates the development of the prefrontal cortex during adolescence and is altered in psychiatric patients. Transl. Psychiatry 3, e338 (2013).
32. Horzinski, L. et al. Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disorders. PLoS ONE 4, e8318 (2009).
33. Mincic, A. M. Neuroanatomical correlates of negative emotionality-related traits: a systematic review and meta-analysis. Neuropsychologia 77, 97-118 (2015).
34. Sexton, C. E., Mackay, C. E. & Ebmeier, K. P. A systematic review of diffusion tensor imaging studies in affective disorders. Biol. Psychiatry 66, 814-823 (2009).
35. De Falco, S. The discovery of placenta growth factor and its biological activity. Exp. Mol. Med. 44, 1-9 (2012).
36. Xie, T. et al. VEGF-related polymorphisms identified by GWAS and risk for major depression. Transl. Psychiatry 7, e1055 (2017).
37. Viglietto, G. et al. Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11, 1569-1579 (1995).
38. Korevaar, T. I. et al. Soluble Flt1 and placental growth factor are novel determinants of newborn thyroid (dys)function: the generation R study. J. Clin. Endocrinol. Metab. 99, E1627-E1634 (2014).
39. Oura, H. et al. A critical role of placental growth factor in the induction of inflammation and edema formation. Blood 101, 560-567 (2003).
40. Luttun, A. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat. Med. 8, 831-840 (2002).
41. Carmeliet, P. et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat. Med. 7, 575-583 (2001).
42. Yoo, S. A. et al. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation. Arthritis Rheum. 60, 345-354 (2009).
43. Lijnen, H. R. et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55, 2698-2704 (2006).
44. Chappell, L. C. et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study. Circulation 128, 2121-2131 (2013).
45. Bauer, M., Goetz, T., Glenn, T. & Whybrow, P. C. The thyroid-brain interaction in thyroid disorders andmood disorders. J. Neuroendocrinol. 20, 1101-1114 (2008).
46. Bergink, V. et al. Pre-eclampsia and first-onset postpartum psychiatric episodes: a Danish population-based cohort study. Psychol. Med. 45, 3481-3489 (2015).
47. Takahashi, H. C. A. Protein tyrosine phosphatases PTPo, PTPo, and LAR: presynaptic hubs for synapse organization. Trends Neurosci. 36, 522-534 (2013).
48. Smith, D. J. et al. Genome-wide analysis of over 106,000 individuals identifies 9 neuroticism-associated loci. Mol. Psychiatry 21, 749-757 (2016).
49. Broome, M. R., He, Z., Iftikhar, M., Eyden, J. & Marwaha, S. Neurobiological and behavioural studies of affective instability in clinical populations: a systematic review. Neurosci. Biobehav. Rev. 51, 243-254 (2015).
50. Insel, T. The NIMH research domain criteria (RDoC) project: precision medicine for psychiatry. Am. J. Psychiatry 171, 395-397 (2014).